Literature DB >> 27830232

Improving Evaluation to Address the Unintended Consequences of Health Information Technology:. a Position Paper from the Working Group on Technology Assessment & Quality Development.

F Magrabi1, E Ammenwerth, H Hyppönen, N de Keizer, P Nykänen, M Rigby, P Scott, J Talmon, A Georgiou.   

Abstract

BACKGROUND AND OBJECTIVES: With growing use of IT by healthcare professionals and patients, the opportunity for any unintended effects of technology to disrupt care health processes and outcomes is intensified. The objectives of this position paper by the IMIA Working Group (WG) on Technology Assessment and Quality Development are to highlight how our ongoing initiatives to enhance evaluation are also addressing the unintended consequences of health IT.
METHODS: Review of WG initiatives
Results: We argue that an evidence-based approach underpinned by rigorous evaluation is fundamental to the safe and effective use of IT, and for detecting and addressing its unintended consequences in a timely manner. We provide an overview of our ongoing initiatives to strengthen study design, execution and reporting by using evaluation frameworks and guidelines which can enable better characterization and monitoring of unintended consequences, including the Good Evaluation Practice Guideline in Health Informatics (GEP-HI) and the Statement on Reporting of Evaluation Studies in Health Informatics (STARE-HI). Indicators to benchmark the adoption and impact of IT can similarly be used to monitor unintended effects on healthcare structures, processes and outcome. We have also developed EvalDB, a web-based database of evaluation studies to promulgate evidence about unintended effects and are developing the content for courses to improve training in health IT evaluation.
CONCLUSION: Evaluation is an essential ingredient for the effective use of IT to improve healthcare quality and patient safety. WG resources and skills development initiatives can facilitate a proactive and evidence-based approach to detecting and addressing the unintended effects of health IT.

Entities:  

Keywords:  Medical informatics; evaluation studies; evidence-based medicine; information systems; patient safety

Mesh:

Year:  2016        PMID: 27830232      PMCID: PMC5171579          DOI: 10.15265/IY-2016-013

Source DB:  PubMed          Journal:  Yearb Med Inform        ISSN: 0943-4747


  32 in total

Review 1.  Future directions in evaluation research: people, organizational, and social issues.

Authors:  B Kaplan; N T Shaw
Journal:  Methods Inf Med       Date:  2004       Impact factor: 2.176

2.  Categorizing the unintended sociotechnical consequences of computerized provider order entry.

Authors:  Joan S Ash; Dean F Sittig; Richard H Dykstra; Kenneth Guappone; James D Carpenter; Veena Seshadri
Journal:  Int J Med Inform       Date:  2006-06-21       Impact factor: 4.046

3.  "e-Iatrogenesis": the most critical unintended consequence of CPOE and other HIT.

Authors:  Jonathan P Weiner; Toni Kfuri; Kitty Chan; Jinnet B Fowles
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

4.  The extent and importance of unintended consequences related to computerized provider order entry.

Authors:  Joan S Ash; Dean F Sittig; Eric G Poon; Kenneth Guappone; Emily Campbell; Richard H Dykstra
Journal:  J Am Med Inform Assoc       Date:  2007-04-25       Impact factor: 4.497

Review 5.  Computer Rx: more harm than good?

Authors:  R Wall
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

6.  Evidence Based Health Informatics: 10 Years of Efforts to Promote the Principle. Joint Contribution of IMIA WG EVAL and EFMI WG EVAL.

Authors:  M Rigby; E Ammenwerth; M-C Beuscart-Zephir; J Brender; H Hyppönen; S Melia; P Nykänen; J Talmon; N de Keizer
Journal:  Yearb Med Inform       Date:  2013

7.  STARE-HI - Statement on Reporting of Evaluation Studies in Health Informatics: explanation and elaboration.

Authors:  J Brender; J Talmon; N de Keizer; P Nykänen; M Rigby; E Ammenwerth
Journal:  Appl Clin Inform       Date:  2013-07-24       Impact factor: 2.342

8.  Recommendations of the International Medical Informatics Association (IMIA) on Education in Biomedical and Health Informatics. First Revision.

Authors:  John Mantas; Elske Ammenwerth; George Demiris; Arie Hasman; Reinhold Haux; William Hersh; Evelyn Hovenga; K C Lun; Heimar Marin; Fernando Martin-Sanchez; Graham Wright
Journal:  Methods Inf Med       Date:  2010-01-07       Impact factor: 2.176

9.  Quality of Health IT Evaluations.

Authors:  Pirkko Nykänen; Johanna Kaipio
Journal:  Stud Health Technol Inform       Date:  2016

10.  Using FDA reports to inform a classification for health information technology safety problems.

Authors:  Farah Magrabi; Mei-Sing Ong; William Runciman; Enrico Coiera
Journal:  J Am Med Inform Assoc       Date:  2011-09-08       Impact factor: 4.497

View more
  3 in total

Review 1.  Evaluation in Life Cycle of Information Technology (ELICIT) framework: Supporting the innovation life cycle from business case assessment to summative evaluation.

Authors:  Polina V Kukhareva; Charlene Weir; Guilherme Del Fiol; Gregory A Aarons; Teresa Y Taft; Chelsey R Schlechter; Thomas J Reese; Rebecca L Curran; Claude Nanjo; Damian Borbolla; Catherine J Staes; Keaton L Morgan; Heidi S Kramer; Carole H Stipelman; Julie H Shakib; Michael C Flynn; Kensaku Kawamoto
Journal:  J Biomed Inform       Date:  2022-02-12       Impact factor: 6.317

2.  Engaging the disability community in informatics research: rationales and practical steps.

Authors:  Rupa S Valdez; Sophie E Lyon; Claire Wellbeloved-Stone; Mary Collins; Courtney C Rogers; Kristine D Cantin-Garside; Diogo Gonclaves Fortes; Chung Kim; Shaalini S Desai; Jessica Keim-Malpass; Raja Kushalnagar
Journal:  J Am Med Inform Assoc       Date:  2022-10-07       Impact factor: 7.942

Review 3.  Health Information Technology in Healthcare Quality and Patient Safety: Literature Review.

Authors:  Sue S Feldman; Scott Buchalter; Leslie W Hayes
Journal:  JMIR Med Inform       Date:  2018-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.